Cylexin for Reduction of Reperfusion Injury in Infant Heart Surgery

Clinical trial NCT00226369 · COMPLETED

Trial details

NCT number: NCT00226369
Sponsor: Boston Children's Hospital
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Congenital Heart Defects

Start date: 1997-12-01
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.